Disability progression in relapsing MS tends to follow one of four distinct patterns, according to a new study.

Sanofi agreed to buy vaccine specialist Dynavax Technologies in a $2.2 billion cash deal, turning to dealmaking in a bid to move past pipeline setbacks.

Sanofi provides update on tolebrutinib regulatory submission in non-relapsing secondary progressive multiple sclerosisParis, December 24, 2025.

When the first spasm hit, it was sharp, sudden, and paralyzing. Tamika Luciano thought her life was ending. The entire left side of her body seized. Her face tightened, her limbs stiffened, and for ...

The agreement will lower the cost of certain drugs for asthma, some cancers, HIV and Type 2 diabetes, among other conditions.

Multiple sclerosis (MS) is a chronic autoimmune disease characterized by the disruption of nerve signals and various ...

Rodríguez-Otero is medical coordinator of the Central Unit for Clinical Trials; associate clinical professor, preclinical and ...

The over-the-counter supplement lipoic acid may have a small beneficial effect in slowing the loss of gray matter in the ...

The over‐the‐counter supplement lipoic acid may have a small beneficial effect in slowing the loss of gray matter in the ...

As she prepares to change medications for her MS, columnist Leigh Anne Nelson explores the U.S. government’s registry on ...

A U.S. regulatory decision on tolebrutinib will again be delayed while a late-stage trial of the drug for a different form of ...

ST. LOUIS, June 1, 2017 /PRNewswire/ -- Express Scripts (NASDAQ: ESRX) today extended its leadership in innovative, value-based care with two new Express Scripts SafeGuardRx ® programs: the Pulmonary ...